Answers drawn from our clinical and patient education material.
Wharton's Jelly is a human cell and tissue product (HCTP). As described in our clinical education material, these are structural allografts meant to supplement local cartilage defects.
No. As stated in our patient education material: these products are not drugs and do not treat diseases, but they can support your body's natural healing processes.
Our clinical education material is explicit: providers should avoid unregulated terms like “stem cells” and instead focus on tissue-specific supplementation for cartilage-based defects. Using the term in clinical practice is described as scientifically inaccurate and legally risky.
They supply collagenic growth factors (like type I, II, and III collagen) that may help the body heal itself at a cellular level—especially when inflammation is controlled.
Education and clinical support are provided through the Institute of Regenerative Education, an independent third party, with protocols curated by Dr. Scott Martin.
Patients who register are matched by ZIP code to a participating provider. Providers control whether they receive referrals, and a provider may hold a ZIP exclusively.